| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.84B | -4.7% |
| Cost of Revenue | $5.13B | -4.7% |
| Gross Profit | $704.5M | -5.0% |
| R&D Expense | $147.0M | -7.5% |
| SG&A Expense | $389.0M | +0.5% |
| Operating Income | $112.3M | -53.5% |
| Interest Expense | $201.1M | +8.1% |
| Pre-tax Income | $1.5M | -97.6% |
| Income Tax | $21.2M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $708.9M | +28.2% |
| Accounts Receivable | $733.0M | +3.4% |
| Inventory | $466.4M | +5.4% |
| Current Assets | $3.63B | +89.8% |
| Total Assets | $6.67B | +31.8% |
| Current Liabilities | $1.23B | +5.0% |
| Long-term Debt | $4.04B | +56.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $411.6M | -9.6% |
| Capital Expenditures | $256.5M | +3.4% |
| Investing Cash Flow | -$169.6M | +33.4% |
| Financing Cash Flow | $1.40B | +993.4% |
| Free Cash Flow | $155.1M | -25.2% |
| -23.7% |
| Net Income | -$19.7M | -156.3% |
| EPS (Basic) | -$0.17 | -158.6% |
| EPS (Diluted) | -$0.17 | -158.6% |
| Total Liabilities |
| $6.03B |
| +34.1% |
| Stockholders' Equity | $640.0M | +13.7% |